Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Rentschler Biopharma SE announced the appointment of Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026.
read more
Halozyme Therapeutics announced the appointment of David Ramsay as President Drug Delivery, effective June 30, 2026.
read more
Rezon Bio announced the appointment of Dr. Hubert Scholze as Chief Business Officer (CBO), effective July 1, 2026.
read more
AustinPx announced its agreement with Thermo Fisher Scientific’s Patheon pharma services for the installation of AustinPx’s KinetiSol™ Technology equipment.
read more
Lonza plans to expand payload-linker manufacturing capacity at its Visp, Switzerland, site to meet rising demand in the fast-growing antibody-drug conjugate (ADC) market.
read more
WuXi Biologics announced that two of its manufacturing facilities in Wuxi — Drug Substance Facility 2 (MFG2) and Drug Product Facility 1 (DP1) — together with its Drug Product Packaging Center (DPPC), have received GMP certification from Brazil's ...
read more
Genoskin plans to double its US footprint with a move to a new 8,000 square foot laboratory and office facility in Salem, Massachusetts, to launch local primary human mast cell production for North American customers.
read more
Adragos Pharma Kawagoe K.K. announced the signing of an agreement with Towa Pharmaceutical to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals.
read more
OrganaBio announced the opening of a new PBMC processing and cryopreservation laboratory at Excellos Labs in San Diego, further strengthening its nationwide network supporting cell therapy developers and clinical trial sponsors.
read more
Celerion announced the expansion of its bioanalytical laboratory in Zurich, Switzerland. The investment strengthens Celerion’s ability to support increasing global demand for bioanalytical services, providing clients with enhanced capacity, rapid ...
read more
Orphan Therapeutics Accelerator has expanded its Orphan ClinDevNet development network with four new strategic partners—OPIS, Uniphar, SK pharmteco and TMC Pharma—to strengthen end-to-end support for ultra-rare disease therapies.
read more
Shilpa Biologicals announced the commissioning of a state-of-the-art Antibody–Drug Conjugate (ADC) GMP manufacturing facility, purpose-built and designed to meet global regulatory approval standards including US FDA, EMA, and other major health ...
read more
WuXi Biologics said its MFG17 drug substance facility at the Shanghai Fengxian site has successfully completed its first GMP production campaign, with manufacturing executed without any deviations.
read more
The FDA is rolling out a series of reforms intended to accelerate and modernize clinical research across the full continuum of drug development, from pre IND interactions through late stage pivotal trials.
read more
Sartorius and LFB BIOMANUFACTURING have expanded their collaboration to provide biopharmaceutical clients with an integrated service offering that spans from cell line development (CLD) through to the first GMP drug substance batch.
read more